» Articles » PMID: 21930109

Polyamidoamine Dendrimer Hydrogel for Enhanced Delivery of Antiglaucoma Drugs

Overview
Journal Nanomedicine
Publisher Elsevier
Date 2011 Sep 21
PMID 21930109
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

From The Clinical Editor: Dendrimer hydrogel was studied as agent for simultaneous delivery of two anti-glaucoma drugs, one hydrophobic and one hydrophilic. Superiority over standard PBS-based formulation was clearly demonstrated for both drugs. The work may be a novel platform for ocular drug delivery.

Citing Articles

Antibiotic-Loaded Dendrimer Hydrogels in Periodontal Bone Regeneration: An In Vitro Release Feasibility Study.

Yesbeck N, Huang D, Carrico C, Madurantakam P, Yang H Gels. 2024; 10(9).

PMID: 39330195 PMC: 11431430. DOI: 10.3390/gels10090593.


Recent Research Progress on Polyamidoamine-Engineered Hydrogels for Biomedical Applications.

Liu L, Li Z, Yang B, Jia X, Wang S Biomolecules. 2024; 14(6).

PMID: 38927024 PMC: 11201556. DOI: 10.3390/biom14060620.


Dendrimer and dendrimer gel-derived drug delivery systems: Breaking bottlenecks of topical administration of glaucoma medications.

Wang J, Li B, Kompella U, Yang H MedComm Biomater Appl. 2024; 2(1).

PMID: 38562247 PMC: 10983815. DOI: 10.1002/mba2.30.


Nanotechnology in Retinal Disease: Current Concepts and Future Directions.

Mehta N, Mehta S J Ocul Pharmacol Ther. 2023; 40(1):3-12.

PMID: 38052063 PMC: 10890960. DOI: 10.1089/jop.2023.0083.


Sustained release of brimonidine from polydimethylsiloxane-coating silicone rubber implant to reduce intraocular pressure in glaucoma.

Huang C, Shen Y, Zhao Y, Zhang Z, Gao S, Hong J Regen Biomater. 2023; 10:rbad041.

PMID: 37303848 PMC: 10247868. DOI: 10.1093/rb/rbad041.